gallstones glp 1 Rapid GLP-1 weight loss spurs gallstones, raises pancreatitis risk 🔷 GLP-1s and Gallbladder Risk:

PMCID: PMC12623600

what matters is your consistency and ability to stick with the schedule long-term

Tirzepatide works by targeting the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, making it the first weight loss and diabetes care medication that targets 2 receptor agonists

Oral GLP-1 medications reduce some barriers associated with injectable administration particularly convenience and needle aversion and may broaden uptake among patients who previously declined injectable therapy

A better understanding of these factors is essential to developing personalized and effective weight management strategies for this population

S.Silveira-RodriguesJ